127 related articles for article (PubMed ID: 27210467)
1. Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma.
Niccolai E; Cappello P; Taddei A; Ricci F; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Coratti A; Cianchi F; Bonello L; Di Celle PF; Prisco D; Novelli F; Amedei A
Int J Oncol; 2016 Jul; 49(1):393-401. PubMed ID: 27210467
[TBL] [Abstract][Full Text] [Related]
2. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
3. [ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].
ZHANG Y; LI M; LIU Y; HAN N; ZHANG K; XIAO T; CHENG S; GAO Y
Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1089-93. PubMed ID: 21159241
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions.
Amedei A; Niccolai E; Benagiano M; Della Bella C; Cianchi F; Bechi P; Taddei A; Bencini L; Farsi M; Cappello P; Prisco D; Novelli F; D'Elios MM
Cancer Immunol Immunother; 2013 Jul; 62(7):1249-60. PubMed ID: 23640603
[TBL] [Abstract][Full Text] [Related]
5. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.
Cappello P; Tomaino B; Chiarle R; Ceruti P; Novarino A; Castagnoli C; Migliorini P; Perconti G; Giallongo A; Milella M; Monsurrò V; Barbi S; Scarpa A; Nisticò P; Giovarelli M; Novelli F
Int J Cancer; 2009 Aug; 125(3):639-48. PubMed ID: 19425054
[TBL] [Abstract][Full Text] [Related]
6. Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F
Clin Exp Med; 2023 Dec; 23(8):5089-5100. PubMed ID: 37910256
[TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
[No Abstract] [Full Text] [Related]
8. Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.
Hsiao KC; Shih NY; Chu PY; Hung YM; Liao JY; Chou SW; Yang YY; Chang GC; Liu KJ
Oncotarget; 2015 Oct; 6(33):35073-86. PubMed ID: 26551021
[TBL] [Abstract][Full Text] [Related]
9. Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.
Lee JY; Choi IA; Kim JH; Kim KH; Lee EY; Lee EB; Lee YM; Song YW
BMC Musculoskelet Disord; 2015 Aug; 16():190. PubMed ID: 26265263
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.
Cappello P; Rolla S; Chiarle R; Principe M; Cavallo F; Perconti G; Feo S; Giovarelli M; Novelli F
Gastroenterology; 2013 May; 144(5):1098-106. PubMed ID: 23333712
[TBL] [Abstract][Full Text] [Related]
11. Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma.
Rittmann MC; Hussung S; Braun LM; Klar RFU; Biesel EA; Fichtner-Feigl S; Fritsch R; Wittel UA; Ruess DA
Sci Rep; 2021 Apr; 11(1):7499. PubMed ID: 33820913
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation.
Capello M; Caorsi C; Bogantes Hernandez PJ; Dametto E; Bertinetto FE; Magistroni P; Rendine S; Amoroso A; Novelli F
Immunol Lett; 2015 Sep; 167(1):11-6. PubMed ID: 26096821
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.
Vicente D; Lee AJ; Hall CS; Lucci A; Lee JE; Kim MP; Katz MHG; Hurd MW; Maitra A; Rhim Md AD; Tzeng CD
J Surg Res; 2019 Nov; 243():90-99. PubMed ID: 31170555
[TBL] [Abstract][Full Text] [Related]
14. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.
Arnoletti JP; Zhu X; Almodovar AJ; Veldhuis PP; Sause R; Griffith E; Corpus G; Chang JC; Fanaian N; Litherland SA
Pancreas; 2017 Jan; 46(1):116-123. PubMed ID: 27400259
[TBL] [Abstract][Full Text] [Related]
15. Alpha-Enolase (
Cappello P; Principe M; Bulfamante S; Novelli F
Front Biosci (Landmark Ed); 2017 Jan; 22(5):944-959. PubMed ID: 27814656
[TBL] [Abstract][Full Text] [Related]
16. The potential significance of alpha-enolase (ENO1) in lung adenocarcinomas - A utility of the immunohistochemical expression in pathologic diagnosis.
Okudela K; Mitsui H; Matsumura M; Arai H; Shino K; Sekine A; Woo T; Suzuki T; Ishikawa Y; Umeda S; Tajiri M; Masuda M; Ohashi K
Pathol Int; 2017 Dec; 67(12):602-609. PubMed ID: 29090499
[TBL] [Abstract][Full Text] [Related]
17. Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma.
Okada K; Kawai M; Tani M; Hirono S; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):648-53. PubMed ID: 24764208
[TBL] [Abstract][Full Text] [Related]
18. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer.
Abue M; Yokoyama M; Shibuya R; Tamai K; Yamaguchi K; Sato I; Tanaka N; Hamada S; Shimosegawa T; Sugamura K; Satoh K
Int J Oncol; 2015 Feb; 46(2):539-47. PubMed ID: 25384963
[TBL] [Abstract][Full Text] [Related]
20. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.
Tsai ST; Chien IH; Shen WH; Kuo YZ; Jin YT; Wong TY; Hsiao JR; Wang HP; Shih NY; Wu LW
Eur J Cancer; 2010 Jun; 46(9):1712-23. PubMed ID: 20435467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
